Första AP-fonden’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-298,277
Closed -$13.9M 274
2019
Q3
$13.9M Buy
298,277
+71,000
+31% +$3.3M 0.58% 41
2019
Q2
$11.9M Hold
227,277
0.53% 47
2019
Q1
$15.7M Buy
227,277
+89,300
+65% +$5.99M 0.69% 40
2018
Q4
$8.23M Hold
137,977
0.39% 60
2018
Q3
$16M Sell
137,977
-9,800
-7% -$1.11M 0.64% 43
2018
Q2
$18.7M Sell
147,777
-7,000
-5% -$852K 0.7% 41
2018
Q1
$16.8M Hold
154,777
0.58% 56
2017
Q4
$17M Hold
154,777
0.62% 48
2017
Q3
$15.3M Hold
154,777
0.54% 53
2017
Q2
$15.7M Buy
+154,777
New +$16.7M 0.44% 56

Other funds holding CLB

Första AP-fonden's CLB Position: Q4 2019 in Review

Första AP-fonden sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 298,277 shares — an estimated $13.9M sold.

Första AP-fonden first reported a position in CLB in Q2 2017 and held it in 10 quarters. The position peaked at $18.7M in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Första AP-fonden reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • Första AP-fonden sold 298,277 Core Laboratories shares in Q4 2019, an estimated $13.9M.
  • Första AP-fonden first reported a position in Core Laboratories in Q2 2017 and held it in 10 quarters.
  • Första AP-fonden's Core Laboratories position peaked at $18.7M in Q2 2018.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Första AP-fonden's 13F filing for Q4 2019, filed 12 Feb 2020.